Search

The article presents analysis of screening of markers of infections in donors using the nucleic amplification technique (NAT) within 4 years. The comparison is made with similar international indices and evaluation was applied to efficiency of the given technique in Kazakhstan. The study established that productivity of NAT technique in Kazakhstan significantly exceeds average international values. The implementation of the given technique permitted to prevent transfusion of infected blood.

The historical concentration of thrombocytes is an average of three subsequent concentrations of thrombocytes before donation (during two years) in blood of donors. The evaluation was applied to characteristics of historical concentration of thrombocytes concerning concentration of thrombocytes in blood of 99 regular donors before every donation of apheresis thrombocytes. It is established that less than 20% dispersion between historical concentration of thrombocytes and value obtained in day of donation is observed in 96% of regular donors. The average concentration of thrombocytes before three subsequent donations of apparatus apheresis in males is statistically higher than in females: 235,2±6,7 and 222,1±11,0 (× 109 cells/l) correspondingly (p0,05). The concentration of thrombocytes has no relationship with intervals between donations. There is no statistically significant differences between historical concentration of thrombocytes and concentration of thrombocytes before fourth donation and in general and between separate donations both in males and females. It is appropriate to analyze quality of concentrates of thrombocytes received through program accounting historical concentration of thrombocytes.

The prevalence and incidence of the infections among Russian blood donors in 2010-2012 was determined. The estimated residual risk of the transfusion infection was as follows: for HIV - 16.2, HCV - 33.7; HBV - 97.1 per 1 million donations. In the information system of the blood service AIST data should be divided based on the posi- tive results of screening and confirmatory tests for markers of the infection. High risk of the transfusion infection with HIV, hepatitis B and C stimulates the active implementation of the measures for increasing the safety of blood: the selection of donors, increasing the sensitivity of infections screening methods, inactivation of patho- gens in blood components, and transfusion management appointment at the clinic.

Since the first successful haematopoietic stem cell transplantation (HSCT) using cord blood from a sibling in 1988 and the establishment of the first public umbilical cord blood bank in New York Blood Center in 1992, umbilical cord blood banks have been instituted in many countries. Funding was received from regular blood banks, health councils, charity funds or commercial investments. The international medical society is indebted to the New York Blood Center for publishing their procedures and EuroCord for fighting a patent on cord blood processing. Although it is unknown how many cord blood samples are currently banked and have been transplanted worldwide, the figures of the international registration of World Marrow Donor Association (WHDA) show an increase of cord blood use, in addition to other sources of unrelated HSCT (Fig. 1). Cord blood for HSCT is, in addition to national/regional use, exchanged worldwide. Donor counselling, human leucocyte antigen (HLA)-typing, tests for transmittable diseases and product quality control requirements to comply with (inter)national [AABB, Paul-Ehrlich-Institut, NetCord/ Foundation for the Accreditation of Cellular Therapy (FACT)] standards are expensive, making storage of cord blood for unrelated allogeneic haematopoietic transplantation currently a loss-making activity, not particularly attractive for private enterprise. In the last years, hopes have been fueled that other stem cells in cord blood may be used for future repair of metabolic or degenerative diseases. Autologous or personal cord blood banking appeals to individual initiatives and private funding; money is desperately needed by allogeneic cord blood banks, and it would be much better if it could

The prevalence and incidence of infections among 28,248 blood donors in Astana in 2012 was determined. The estimated residual risk of the transfusion infection was as follows: for HIV--1,2, HCV--137,7, HBV--125,4 per 1 million donations. High risk of transfusion infection with HIV, hepatitis B, and C stimulates the active implementation of the measures for increasing the safety of blood: the selection of donors, increasing the sensitivity of infections screening methods, inactivation of pathogens in blood components and transfusion management appointment at the clinic.

The article presents the results of changes of concentration of DNA of viral hepatitis B under conservation in frozen conditions. The optimal scheme of preparing and delivering samples of donor blood stored up in institutions of blood service of the Irkutskaia oblast for molecular biological testing was elaborated.

The article deals with the results of work of Krasnoyarsk kray blood center immune hematologic laboratory concerning selection of erythrocytes in 2003-2010. In Krasnoyarsk kray, the portion of transfusions of individually selected erythrocytes increases and reached 31.9%. The setting up of register of donors typed by Ab0 and Rhesus systems makes it possible to implement effectively the individual selection of erythrocytes in optimal time-frame and in amount needed in clinics.

The cost-effectiveness of prescreening for alanine aminotransferase (ALT) activity was evaluated in blood donors before donation. Since September 15, 2006, the Krasnodar Territory blood transfusion station has examined more than 32 thousand donors in this fashion. A Reflotron Plus biochemical analyzer (Roche Diagnostics, Switzerland) was used. In 2008, 1230 subjects with increased ALT activity were withdrawn from donation. A total of 17,096 persons were examined. Their examination cost 1,219,457.8 rubles. Non-productive outlays of 7,773,919.8 rubles were prevented. The savings amounted to 6,554,462.12 rubles. Prescreening for ALT was found to be cost-effective if the rate of positive results in the donor population was 1.13% or more.

Transfusion-transmitted viral infection in Russia is most commonly due to plasma transfusion. Methylene blue treatment (Macotronic) is the most practical technology for plasma viral inactivation. It was shown to provide the maximal level of inactivation of both enveloped and non-enveloped viruses. It is preferable to perform inactivation of single plasma units, which can be done at any healthcare facility. The first experience in methylene blue plasma virus inactivation revealed good clinical results and social satisfaction.

The incidence of viral hepatitis was compared in donors (n = 184532) with the increased or normal activity of alanine aminotransferase (ALT) without the specific markers of hepatitis - HbsAg and anti-HCV. The activity of ALT was found to retain its diagnostic values in preventing blood-transmitted diseases only with the insufficient sensitivity of the specific markers of viral hepatitis in donors. A prospective case-control study of the specific markers of the infections may be recommended to assess the quality of work of diagnostic laboratories.

6,744 persons were examined for the presence of antibodies to hepatitis C virus (HCV) before blood donation (4,219 persons in Moscow and 2,525 persons in St. Petersburg). The serum samples found to contain antibodies to HCV were additionally studied by the immunoblot techniques. The positive results of antibody screening were registered in 78 persons: 26 persons in Moscow (0.62%) and 52 in St. Petersburg (2.05%). In both cities the positive results of screening were confirmed in 62% of cases. Different occurrence of the profile with the presence of antibodies to all fragments of the virus: 52% in Moscow, 12% in St. Petersburg (chi2 = 12.11; p0.001). Considerable differences were also registered in the spread of individual antibodies.

Costs of electric power used for storage of freshly frozen plasma (FFP) were compared for refrigerators most widely used in Russian medical facilities. The minimal costs (2763.43 R) are those obtained for storage of 5000 FFP units in 12 plasma freezers, MDF-U536 (Sanyo, Japan). When 30,000 plasma units are stored the cost efficiency of power consumption is higher for the TELEDOOR freezer (Germany) versus MDF-U536. It can be assumed that, as the electric power cost increases, it will be more attractive to store FFP in liquid nitrogen vapor (MABAG, Germany). The above technology is registered in Russia; however, its application is still problematic due to economic reasons.

A conclusion is made, on the basis of independent research results and published data, on the need to verify, compulsorily, the screening finding of donor blood for hepatitis virus by immunoblot and, in extra complicated cases, by PCR.

Inactivation or elimination of (possibly) contaminated viruses from a pool of prepared several hundreds or thousands of donor-blood samples are an obligatory stage in the donor-blood preparation process. Virus-inactivation is verified through contaminating the basic material with viruses. The quality control of blood preparations, according to the Russian compulsory regulations, must include the testing of ready blood-based drugs for a lack of antibodies to HIV, hepatitis C virus and hepatitis B virus by using the test systems, which could not be exactly designed for the above purpose. Therefore, the below tasks are vital for the Russian Blood Service: 1) cancellation of the norm (belonging to the regulations of the quality control of blood preparations) to test the blood preparations for a lack of antibodies to HIV, hepatitis C virus and to the surface antigen of hepatitis B virus because it is biologically inexpedient and has no analogues in the world practice; 2) introduction of the virus-inactivation methods into the practice of plasma processing; 3) establishment of a special center that would evaluate the efficiency of the virus-inactivation methods used by producers of blood-based preparations; and 4) introduction of the methods of genetic testing of HIV, hepatitis B and C viruses into monitoring the quality of donor-sera pools that are later used in preparations' manufacturing.

It is important to well balance the loads of the opposite cups with plastic blood containers in order to correctly separate the donor blood into its components through centrifugation. A new balancer for centrifugation cups (USC5-01, manufacturer--Biophysical Instruments Ltd., Moscow) was tested at the Blood Center of Russia's Health Ministry. The original weights of all cups placed on the device weight sensors differed in all cases by readings of the light-emitting diode scale, which necessitated an appropriate balancing. The weight differences varied from 4 to 20 g, i.e. from 1 to 5 green lamps). The testing of the device verified its simplicity, convenience, and a shorter time spent on each balancing procedure; the device response lag to balancing made only 2-3 sec. The minimal out-of-balance index did not exceed 4 g, which ensures the obtaining of components meeting the requirements applied to them.

Laboratory testing of donor blood is the key point in prevention of hemotransmissive syphilis. The probability of using diagnostic EIA kit RecombiBest antipallidum-strip (AO Vektor-Best, Novosibirsk) is assessed. Ninety-two donor sera were tested. For assessing the sensitivity of the test system, 11 sera of syphilis patients were titrated by double dilutions 1:10 to 1:1280 for each strip. In parallel with this, antibodies to T. pallidum were assessed in the precipitation microtest. EIA proved to be not only highly specific, but more sensitive than precipitation microtest. Antibodies to T. pallidum are detected by EIA in serum dilutions at least two times higher than the minimal titers in the precipitation test. Thus, the above diagnostic kit is recommended for screening of donors of blood and its components.

The Avicenna test system (St. Petersburg) for detecting antibodies to hepatitis C is assessed. Two-hundred and ten sera with increased SGPT activity and 73 samples seropositive in screening by the Aquapast test system (St. Petersburg) were examined. Avicenna system with 3 synthetic peptides as the test objects is characterized by a higher sensitivity and specificity and is recommended for practical use at blood service institutions.

In the work the factors, rendering essential influence on organization of donorship in modern army conditions are systematized. The organization of donorship should be connected to functioning of territorial system of medical maintenance of the Armed Forces of RF. It assumes presence of four organizational levels: central, district, zone and garrison. Perfecting the system of organization of donorship, we should be guided by the following conducting principles: maximum maintenance of safety of donorship; wide introduction of a method of plasmacytopheresis in work of establishments and subdivisions of blood supply service; organization of autodonorship and quota of the donors of an emergency reserve in each military-medical establishment; reliable maintenance of revealing of markers of hemotransmissible infections at inspection of the donors.

Serological markers of Epstein-Barr virus (EBV) infection has been investigated in 28 patients with infectious endocarditis. In 75% of patients IgM antibodies to "early" antigen of the virus which are the marker of active viral infection occurred vs 6.2% among healthy blood donors. Specific for infectious endocarditis reaction profile (anti-EBV combination in one person) indicates reactivation of latent viral infection. The conclusion is made on the necessity of further investigation of both the role of EBV in pathogenesis of pyoseptic diseases and immunologic mechanisms for reactivation of latent viral infections.

The spread of IgG antibodies to cytomegalovirus and Toxoplasma in the blood sera of 323 donors of hemocomponents was studied. Among young males in the northwestern region of Russia three fourths were found to be seropositive to cytomegalovirus and one third, to Toxoplasma. In older ages the proportion of seropositive persons somewhat increased. In donors with blood group O (I) antibodies to cytomegalovirus occurred almost twice as often (91%) as in donors with blood group AB (IV) (47%). Among donors with blood group AB (IV) the proportion of persons seropositive to Toxoplasma (54%) was twice as great as that among donors with blood group O (I) (27%).

The sensitivities and specificities of enzyme immunoassay (EIA) kits for the detection of antibodies to hepatitis C virus (HCV) were compared in donor blood screening. A total of 3308 donors were examined using Akvapast immunodiagnosticum (St. Petersburg), lot 12. Anti-HCV antibodies were detected in 43 (1.3%) subjects. Blood sera of these donors were additionally investigated using other lots of Akvapast, Hepascan (Bioservice, Moscow), Blot-0.5 (Bioservice, Moscow), and immunoComb (France). The studies demonstrated that none of the agents used can be acknowledged as ideally sensitive and specific for the detection of anti-HCV antibodies. Maximally sensitive diagnostic kits should be preferred for the screening of donors of blood components and for other mass surveys. Highly-specific test systems are advisable for profound examinations and diagnostic monitoring. The creation of a system of reference and expert diagnosis of hepatitis C remains a pressing task.

The efficacy of specific and substitute markers of hepatitis C was compared in donor blood screening. 2615 blood donors were examined using two EIA kits for detection of HCV antibodies. The presence of nonspecific markers of non-A non-B hepatitis was also checked. 1.3% of the donors were found to carry HCV antibodies. This necessitates donor blood testing for anti-HCV antibodies using EIA. Such measure reduces three-fold the risk of the virus transmission with blood components and preparations. The preference should be given to more sensitive test systems of the second generation, whereas less sensitive, but more specific, test systems are more valuable for accurate diagnosis and treatment effects assessment in HCV infection. It would be appropriate to perform compulsory examinations for HCV infection in medical staff. This will entail efforts on development of the infection diagnostic verification criteria and preventive measures.

The article contains data on viral hepatitis C, its etiological factor, epidemiology, methods of diagnosis and prophylaxis. It's high time to conduct 100% screening control of donors for viral hepatitis C antibody, using national test system of fermental analysis. The authors worked out the method of "dry drop" to study the serum for hepatitis C virus antibody.